Company profile for Alvotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alvotech is a privately owned, fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high quality biosimilar products. We are specialists in biogeneric product creation, all along the value chain from cell line development to commercial manufacturing. Our common goal: to be a global leader in the biosimilar space and to deliver high quality cost competitive products to pat...
Alvotech is a privately owned, fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high quality biosimilar products. We are specialists in biogeneric product creation, all along the value chain from cell line development to commercial manufacturing. Our common goal: to be a global leader in the biosimilar space and to deliver high quality cost competitive products to patients worldwide. We come from all around the world, bringing literally thousands of years of combined knowledge and expertise to our mission.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Iceland
Address
Address
Sæmundargötu 15-19, 101 Reykjavík
Telephone
Telephone
+354 522 2900
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/31/3211924/0/en/Alvotech-Secures-Term-Loan-Facility-of-USD-100-Million.html

GLOBENEWSWIRE
31 Dec 2025
Company Updates Own Shares Holdings
Company Updates Own Shares Holdings

29 Dec 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/12/29/3211120/0/en/Changes-in-company-s-own-shares.html

GLOBENEWSWIRE
29 Dec 2025

https://www.globenewswire.com/news-release/2025/12/22/3208951/0/en/Alvotech-announces-European-launch-of-first-in-market-biosimilar-to-Simponi-golimumab-globally-by-partner-Advanz-Pharma.html

GLOBENEWSWIRE
22 Dec 2025

https://www.globenewswire.com/news-release/2025/12/19/3208323/0/en/Alvotech-and-Teva-Secure-U-S-Settlement-Date-for-AVT06-a-Proposed-Biosimilar-to-Eylea.html

GLOBENEWSWIRE
19 Dec 2025

https://www.drreddys.com/cms/sites/default/files/2025-11/DRL-finalpressrelease-24thNov2025-Deno.pdf

PRESS RELEASE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/24/3193283/0/en/Alvotech-Announces-Approval-of-AVT03-a-Biosimilar-to-Prolia-and-Xgeva-denosumab-in-the-European-Economic-Area.html

GLOBENEWSWIRE
24 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty